Recall Sours Abbott’s Infant Formula Results; COVID-19 Test Sales Expected To Cool

Abbott's nutrition sales, adult as well as pediatric products, during Q1 dropped reported 7% to $1.89bn as it recalled Similac and other infant formula brands. • Source: Alamy
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography